Jamjoom Pharmaceuticals Factory Company (TADAWUL:4015)
158.60
-4.40 (-2.70%)
Mar 10, 2025, 11:44 AM AST
TADAWUL:4015 Balance Sheet
Financials in millions SAR. Fiscal year is January - December.
Millions SAR. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2018 |
---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2018 |
Cash & Equivalents | 261.67 | 284.28 | 141.18 | 112.63 | 235.55 | Upgrade
|
Short-Term Investments | 0.64 | 0.8 | 1.06 | 39.36 | 20.53 | Upgrade
|
Trading Asset Securities | - | 5.16 | 5.12 | - | - | Upgrade
|
Cash & Short-Term Investments | 262.31 | 290.24 | 147.36 | 151.99 | 256.08 | Upgrade
|
Cash Growth | -9.62% | 96.96% | -3.05% | -40.65% | 27.55% | Upgrade
|
Accounts Receivable | 443.52 | 332.13 | 352.36 | 366.9 | 418.22 | Upgrade
|
Other Receivables | - | 22.2 | 28.59 | 20.58 | 18.02 | Upgrade
|
Receivables | 443.52 | 360.15 | 389.27 | 404.93 | 454.72 | Upgrade
|
Inventory | 270.88 | 233.92 | 131.86 | 135.17 | 129.2 | Upgrade
|
Prepaid Expenses | 51.97 | 3.99 | 4.52 | 3.09 | 2.54 | Upgrade
|
Other Current Assets | - | 18.41 | 15.08 | 4.48 | 4.17 | Upgrade
|
Total Current Assets | 1,029 | 906.7 | 688.08 | 699.67 | 846.71 | Upgrade
|
Property, Plant & Equipment | 673.93 | 698.3 | 705.05 | 713.87 | 613.56 | Upgrade
|
Long-Term Investments | 57.49 | 36.11 | 0.25 | 3.97 | 3.83 | Upgrade
|
Other Intangible Assets | 11.53 | 13.05 | 14.43 | 14.79 | 16.54 | Upgrade
|
Other Long-Term Assets | - | - | - | - | 15.02 | Upgrade
|
Total Assets | 1,772 | 1,654 | 1,408 | 1,432 | 1,496 | Upgrade
|
Accounts Payable | 172.71 | 67.98 | 39.79 | 41.81 | 41.9 | Upgrade
|
Accrued Expenses | - | 66.75 | 51.98 | 59.55 | 46.15 | Upgrade
|
Current Portion of Long-Term Debt | - | - | - | - | 95.02 | Upgrade
|
Current Portion of Leases | 0.26 | 0.25 | 0.24 | 0.25 | 0.26 | Upgrade
|
Current Income Taxes Payable | 28.8 | 25.51 | 17.72 | 19.74 | 20.59 | Upgrade
|
Other Current Liabilities | - | 19.49 | 17.27 | 17.01 | 35.15 | Upgrade
|
Total Current Liabilities | 201.76 | 179.97 | 126.99 | 138.36 | 239.07 | Upgrade
|
Long-Term Leases | 1.83 | 2.16 | 2.4 | 1.72 | 1.97 | Upgrade
|
Total Liabilities | 281.03 | 249.84 | 191.55 | 200.66 | 316.59 | Upgrade
|
Common Stock | 700 | 700 | 700 | 100 | 100 | Upgrade
|
Retained Earnings | 950.81 | 811.99 | 591.35 | 1,170 | 1,113 | Upgrade
|
Comprehensive Income & Other | -160.21 | -107.66 | -75.08 | -37.88 | -33.73 | Upgrade
|
Total Common Equity | 1,491 | 1,404 | 1,216 | 1,232 | 1,179 | Upgrade
|
Shareholders' Equity | 1,491 | 1,404 | 1,216 | 1,232 | 1,179 | Upgrade
|
Total Liabilities & Equity | 1,772 | 1,654 | 1,408 | 1,432 | 1,496 | Upgrade
|
Total Debt | 2.09 | 2.4 | 2.64 | 1.97 | 97.24 | Upgrade
|
Net Cash (Debt) | 260.22 | 287.84 | 144.72 | 150.03 | 158.84 | Upgrade
|
Net Cash Growth | -9.60% | 98.89% | -3.53% | -5.55% | -3.45% | Upgrade
|
Net Cash Per Share | 3.72 | 4.11 | 2.07 | 15.00 | 15.88 | Upgrade
|
Filing Date Shares Outstanding | 70.18 | 70 | 70 | 10 | 10 | Upgrade
|
Total Common Shares Outstanding | 70.18 | 70 | 70 | 10 | 10 | Upgrade
|
Working Capital | 826.92 | 726.73 | 561.09 | 561.3 | 607.64 | Upgrade
|
Book Value Per Share | 21.24 | 20.06 | 17.38 | 123.16 | 117.91 | Upgrade
|
Tangible Book Value | 1,479 | 1,391 | 1,202 | 1,217 | 1,163 | Upgrade
|
Tangible Book Value Per Share | 21.08 | 19.88 | 17.17 | 121.68 | 116.25 | Upgrade
|
Land | - | 59.73 | 60.46 | 62.59 | 62.58 | Upgrade
|
Buildings | - | 224.31 | 177.98 | 176.67 | 153.84 | Upgrade
|
Machinery | - | 564.16 | 515.41 | 510.48 | 488.57 | Upgrade
|
Construction In Progress | - | 252.89 | 329.94 | 325.12 | 249.46 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.